Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Dr. Reddy’s Is in Talks to Enter Japan’s Drug Market

Dr. Reddy’s Laboratories Ltd. is in talks to enter Japan’s generic-drug market, said S. Rajan, a company spokesman.

“We are in early stages of evaluating partnership options as part of our Japan entry strategy,” Rajan said in an e-mail today.

Dr. Reddy’s is in talks with three Japanese drugmakers to buy a stake, ET Now television channel reported yesterday, without saying where it got the information. The three companies are Towa Pharmaceutical Co., Sawai Pharmaceutical Co. and Fuji Pharma Co., the station said.

The Japanese companies denied the report in separate statements to the Tokyo Stock Exchange today.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.